Abbott Laboratories

ABT
NYSE
Last Updated: 6/9/2023 8:03:16 PM
Price
101.69
Changes
0.91
% Change
0.90
Volume
3590558
52 Week
High
115.69
52 Week
Low
93.25
About Abbott Laboratories
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Abbott Laboratories Company Details
CEO:   Mr. Robert B. Ford
Country:   US
Industry:   Medical Devices
Website:   https://www.abbott.com
Exchange:   New York Stock Exchange
IPO\Launch Date:   1937-03-01
Abbott Laboratories Company Executive Details
  Mr. Hubert L. Allen
  Executive Vice President, Gen. Counsel & Sec.
  Ms. Andrea F. Wainer
  Executive Vice President of Rapid & Molecular Diagnostics
  Ms. Melissa Brotz
  Vice President of Public Affairs & Corporation Marketing
  Mr. Robert E. Funck Jr.
  Executive Vice President of Fin. & Chief Financial Officer
  Mr. Scott Michael Leinenweber
  Vice President of Investor Relations, Licensing & Acquisitions

Abbott Laboratories Latest News

Abbott (ABT) Is Considered a Good Investment by Brokers: Is That True?


The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.


Published on: 2023-06-07 10:33:12

Impact on Symbol / Company: ABT

View News

2 Dividend Kings Down 12% and 14% You'll Regret Not Buying on The Dip


Abbott Labs and Johnson & Johnson have raised their payouts for 51 and 60 consecutive years, respectively. Both companies have solid businesses and a proven ability to be successful in the tricky healthcare industry.


Published on: 2023-06-04 10:15:00

Impact on Symbol / Company: ABT

View News

Abbott accuses one of its former scientists of trade-secrets theft in US court


Healthcare company Abbott Laboratories on Tuesday sued one of its former scientists, accusing him in U.S. court of "secretly downloading" sensitive corporate files containing competitive information about nutrition products.


Published on: 2023-05-31 11:51:15

Impact on Symbol / Company: ABT

View News

Abbott (ABT) Reports Upbeat Cardiomems Sensor Study Result


Abbott's (ABT) MONITOR-HF is the third randomized, controlled trial that will provide significant health benefits to indicated heart failure patients.


Published on: 2023-05-30 10:40:06

Impact on Symbol / Company: ABT

View News

Buy Alert: 3 Undervalued High-Yield Gems For Your Retirement


This article discusses three high-yielding stocks for retirees and income-oriented investors: ONEOK, AbbVie, and Realty Income. ONEOK is a cyclical income play with a 6.5% yield, AbbVie offers a high-quality healthcare yield of 4.2%, and Realty Income provides steady and reliable dividend growth with a 5.2% yield.


Published on: 2023-05-26 09:00:00

Impact on Symbol / Company: ABT

View News

How Dexcom and Abbott are moving beyond diabetes with blood sugar monitoring


CNBC spoke with both Abbott and Dexcom about the technology inside continuous glucose monitors and how they see the technology expanding.


Published on: 2023-05-26 08:00:01

Impact on Symbol / Company: ABT

View News

Medical technology is a good space for cover in recession times, says Mizuho's Anthony Petrone


Anthony Petrone, senior medical devices analyst at Mizuho, joins 'The Exchange' to discuss medical technology gaining share, the bull case for Medtronic, and how medication advancements could impact the medtech sector.


Published on: 2023-05-24 14:52:26

Impact on Symbol / Company: ABT

View News

Abbott (ABT) Unveils Late-Breaking Data on Leadless Pacemaker


Abbott (ABT) study analyzes primary safety and efficacy endpoints in the first 300 people enrolled across 55 centers in the United States, Canada and Europe.


Published on: 2023-05-24 13:13:19

Impact on Symbol / Company: ABT

View News

FTC Investigates Abbott For Alleged Collusion in Federal Baby Formula Contract Bids


Abbott, the nation's largest maker of infant formula, is being investigated by the Federal Trade Commission for potentially anti-competitive federal nutrition program bids.


Published on: 2023-05-24 12:40:49

Impact on Symbol / Company: ABT

View News

10 A-Rated Dividend Aristocrats For The Ultimate High-Yield SWAN Portfolio


The debt ceiling crisis is coming down to the wire. We're possibly already out of time to prevent default and just don't know it. UBS estimates a short default could create a 20% bear market and a one-month default could lead to a 44% crash.


Published on: 2023-05-24 07:20:00

Impact on Symbol / Company: ABT

View News

Abbott, other formula makers face FTC investigation for collusion - WSJ


The U.S. Federal Trade Commission is investigating whether baby-formula makers colluded on bids for attractive state contracts, the Wall Street Journal reported on Wednesday.


Published on: 2023-05-24 00:33:11

Impact on Symbol / Company: ABT

View News

Abbott Laboratories: A Mixed, Yet Expensive Bag


Abbott Laboratories is suffering from a reversal of pandemic trends and its own issues around pediatric nutrition. This creates a tough setup for 2023, as valuations remain demanding.


Published on: 2023-05-22 18:04:04

Impact on Symbol / Company: ABT

View News

Grow your Money

We helps you in understanding the science behind growing the money, which will help you diversify your funds as per your requirements and helps in achieving your retirement goals, children education, investment in property, business or any smart looking startup ventures

Services we Offer

We offer several services including expert recommendations & suggestions on buying ETF, Mutual Funds, Bonds, Debt securities, Equities, Property invesments and several others

Live Market Data

We provide you live market data for your analysis, review and looking out for quick buying opportunities to help you